RBFOX3 and Alzheimer disease: When we quantified both the number of SOX2+/NeuN+ cells and of SOX2+/NeuN− cells, the percentage of SOX2+ cells also expressing NeuN was increased in NDAN individuals while it was decreased in both MCI and AD patients as compared to age-matched healthy controls (Fig. 2b).